{
  "generated": "2025-11-06T07:07:39.732416+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/neurological/bacopa-cogn-gen-0121/cognition/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "COGN-GEN-0121_01",
      "year": 2012,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/bacopa-cogn-gen-0121-01",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-01",
      "citation": "COGN-GEN-0121_01 (2012); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/bacopa-cogn-gen-0121-01; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "COGN-GEN-0121_02",
      "year": 2013,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/bacopa-cogn-gen-0121-02",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-02",
      "citation": "COGN-GEN-0121_02 (2013); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/bacopa-cogn-gen-0121-02; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "COGN-GEN-0121_03",
      "year": 2014,
      "design": "randomized controlled trial",
      "journal": "cognition_journal",
      "outcome": "cognitive_decline",
      "population": "Adults with cognitive decline concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/bacopa-cogn-gen-0121-03",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-03",
      "citation": "COGN-GEN-0121_03 (2014); Journal: cognition_journal; Design: randomized controlled trial; Population: Adults with cognitive decline concerns; Outcome: cognitive_decline; DOI: 10.1234/bacopa-cogn-gen-0121-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/bacopa-cogn-gen-0121-01",
      "study_ids": [
        "COGN-GEN-0121_01"
      ],
      "primary_study_id": "COGN-GEN-0121_01",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/bacopa-cogn-gen-0121-02",
      "study_ids": [
        "COGN-GEN-0121_02"
      ],
      "primary_study_id": "COGN-GEN-0121_02",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/bacopa-cogn-gen-0121-03",
      "study_ids": [
        "COGN-GEN-0121_03"
      ],
      "primary_study_id": "COGN-GEN-0121_03",
      "url": "https://doi.org/10.1234/bacopa-cogn-gen-0121-03"
    }
  ],
  "manifest_hash": "sha256:d13e61ca6933e737361d3c54a96c2e6837943741828e3a35ef16148dafeb4533"
}
